Allogene Therapeutics (ALLO) Other Gross PP&E Adjustments (2019 - 2025)
Historic Other Gross PP&E Adjustments for Allogene Therapeutics (ALLO) over the last 7 years, with Q3 2025 value amounting to $104.5 million.
- Allogene Therapeutics' Other Gross PP&E Adjustments fell 2315.59% to $104.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $104.5 million, marking a year-over-year decrease of 2315.59%. This contributed to the annual value of $81.5 million for FY2024, which is 3253.02% up from last year.
- As of Q3 2025, Allogene Therapeutics' Other Gross PP&E Adjustments stood at $104.5 million, which was down 2315.59% from $103.9 million recorded in Q2 2025.
- In the past 5 years, Allogene Therapeutics' Other Gross PP&E Adjustments ranged from a high of $140.9 million in Q2 2024 and a low of $40.4 million during Q4 2022
- Moreover, its 5-year median value for Other Gross PP&E Adjustments was $86.1 million (2024), whereas its average is $87.6 million.
- As far as peak fluctuations go, Allogene Therapeutics' Other Gross PP&E Adjustments plummeted by 4512.82% in 2022, and later soared by 10103.84% in 2024.
- Over the past 5 years, Allogene Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at $73.6 million in 2021, then plummeted by 45.13% to $40.4 million in 2022, then skyrocketed by 52.25% to $61.5 million in 2023, then soared by 32.53% to $81.5 million in 2024, then increased by 28.16% to $104.5 million in 2025.
- Its last three reported values are $104.5 million in Q3 2025, $103.9 million for Q2 2025, and $104.6 million during Q1 2025.